The Patient Protection and Affordable Care Act adds a new provision to the Internal Revenue Code that could provide a significant benefit to small and mid-size companies in the biotechnology industry. The Act, which was signed by President Obama on March 23, authorizes the Secretary of the Treasury to award up to $1 billion in qualifying therapeutic discovery project credits in 2009 and 2010. The credit is equal to 50% of an eligible taxpayer’s qualified investment in a qualifying therapeutic discovery project.
Qualifying therapeutic discovery projects include projects that are designed to treat, prevent, or diagnose diseases or conditions, as well as projects designed to develop products, processes or technologies to further the delivery or administration of therapeutics. Taxpayers must apply to receive the credit, and any taxpayer with 250 or fewer employees is eligible to submit an application. In lieu of the tax credit, eligible taxpayers can apply for a grant equal to 50% of the taxpayer’s qualified investment.
The Act requires the Secretary of the Treasury, in conjunction with the Department of Health and Human Services, to establish a program to consider and certify qualified investments no later than May 21, 2010. Therefore, regulations detailing the required form and content of the credit and grant applications will likely be released in mid-May. In the meantime, there are several steps that taxpayers in the biotech industry could take to prepare for the application process, including evaluating current and planned projects to determine which projects could qualify for the credit and itemizing qualified investment expenses.
For detailed information about the credit, click here.
For media coverage on the topic, click here.
- Partner
Mark Sims practices in the Business Representation & Transactions Group and works primarily in the federal income tax, business planning and healthcare areas. Mark's federal tax practice involves individual, corporate, S ...
Topics/Tags
Select- Securities Law
- SEC
- Securities Regulation
- Cybersecurity and Privacy Law
- Mergers & Acquisitions
- Coronavirus
- Economic Sanctions
- Ohio LLC Act
- Cybersecurity Regulation
- Nasdaq
- Corporate Law
- Tax Planning
- Corporate Tax
- Paycheck Protection Program
- Dodd-Frank
- IRS
- JOBS Act
- FAST Act
- Proxy Access Rules
- Securities Litigation
- Consumer Protection Act
- Corporate Governance
- SEC Enforcement
- Crowdfunding
- Cryptocurrency
- Taxation
- Hedging
- Private Offerings
- Real Estate Law
- Conflict Minerals
- Emerging Growth Companies
- Investors
- Pay Ratio Disclosure
- Intellectual Property
- Technology
- Whistleblower
- Opportunity Zone
- LIBOR
- Accredited Investors
- Sales Tax
- United States Supreme Court
- Online Trading Platforms
- IPO
- Registration Statement
- Executive Compensation
- Health Care Act
- Annual Reports
- Ohio Foreclosure Reform
- Director Compensation
- Family-Controlled Entities
- Gift and Estate Transfers
- Wall Street Reform
- Board of Directors
- Director Independence
- Clawback Rules
- Total Shareholder Return
- Cyber Insurance
- Data Breach
- Lenders
- Receivership Statute
- Regulation A
- Regulation D
- Compensation Committee Certification
- Government Shutdown
- CDEs
- CDFI Fund
- Community Development Entities
- Community Development Financial Institutions Fund
- New Markets Tax Credit
- NMTC
- NMTC Financing
- Regulation Fair Disclosure
- Social Media
- Benefits
- Healthcare Reform
- Litigation
- Marketing
- Public Company Transition Rules
- Tax Credit
- Employment Incentives
- HIRE Act
- Social Security Tax
Recent Posts
- SEC Provides Sample Guidance on Disclosure of Russia-Ukraine Invasion
- Proposed SEC Climate-Related Disclosure Requirements
- Proposed SEC Cybersecurity Rules
- International Unrest and its Impact on M&A
- The United States Ramps Up Severe Economic Sanctions on Russia and Export Controls
- Revised Ohio LLC Statute
- Beware of ‘Spring-Loaded’ Awards: SEC Issues Updated Accounting Guidance
- SEC Opens Floodgates for ESG Proposals
- NYSE Proposes an Amendment to the Shareholder Voting Requirement
- SEC Charges Pearson plc for Misleading Investors About Cyber Breach and Inadequate Disclosure Controls